{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+%28Vehicle+Gel%29&page=4", "query": { "intervention": "Placebo (Vehicle Gel)", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 94, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+%28Vehicle+Gel%29&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+%28Vehicle+Gel%29&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-10T17:17:41.369Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00989014", "title": "Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Erythematotelangiectatic Rosacea" ], "interventions": [ { "name": "CD07805/47", "type": "DRUG" }, { "name": "CD07805/47 placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Galderma R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 122, "start_date": "2009-09", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2021-02-18", "last_synced_at": "2026-10-10T17:17:41.369Z", "location_count": 5, "location_summary": "Hot Springs, Arkansas • Fort Washington, Pennsylvania • Austin, Texas + 2 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Fort Washington", "state": "Pennsylvania" }, { "city": "Austin", "state": "Texas" }, { "city": "College Station", "state": "Texas" }, { "city": "Lynchburg", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00989014" }, { "nct_id": "NCT00801086", "title": "Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alopecia" ], "interventions": [ { "name": "7% (w/v) Tempol alcohol-based gel (MTS-01)", "type": "DRUG" }, { "name": "alcohol-based gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mitos Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2008-11", "completion_date": "2010-06", "has_results": false, "last_update_posted_date": "2008-12-03", "last_synced_at": "2026-10-10T17:17:41.369Z", "location_count": 2, "location_summary": "Tucson, Arizona • Philadelphia, Pennsylvania", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00801086" }, { "nct_id": "NCT06504160", "title": "Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "ShA9 Topical Gel", "type": "DRUG" }, { "name": "Hydrocortisone Ointment", "type": "DRUG" }, { "name": "Clobetasol Ointment", "type": "DRUG" }, { "name": "Fluocinonide Ointment", "type": "DRUG" }, { "name": "Placebo (Vehicle) Topical Gel", "type": "DRUG" }, { "name": "Triamcinolone Ointment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 86, "start_date": "2025-05-22", "completion_date": "2027-02-05", "has_results": false, "last_update_posted_date": "2026-07-02", "last_synced_at": "2026-10-10T17:17:41.369Z", "location_count": 8, "location_summary": "San Diego, California • Denver, Colorado • Chicago, Illinois + 4 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06504160" }, { "nct_id": "NCT02393937", "title": "A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Papulopustular Rosacea", "Erythematotelangiectatic Rosacea" ], "interventions": [ { "name": "Reference: Metronidazole Gel 1%", "type": "DRUG" }, { "name": "Test: Metronidazole Gel 1%", "type": "DRUG" }, { "name": "Placebo Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "bioRASI, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 963, "start_date": "2015-02", "completion_date": "2015-10", "has_results": false, "last_update_posted_date": "2020-09-03", "last_synced_at": "2026-10-10T17:17:41.369Z", "location_count": 27, "location_summary": "Los Angeles, California • San Diego, California • Boca Raton, Florida + 23 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02393937" }, { "nct_id": "NCT06493578", "title": "A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-segmental Vitiligo" ], "interventions": [ { "name": "VYN201 Gel", "type": "DRUG" }, { "name": "Vehicle Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vyne Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 205, "start_date": "2024-06-04", "completion_date": "2025-09-30", "has_results": false, "last_update_posted_date": "2026-04-21", "last_synced_at": "2026-10-10T17:17:41.369Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 39 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06493578" }, { "nct_id": "NCT03798561", "title": "Study to Evaluate ASN008 Topical Gel (TG)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Dermatitis, Atopic", "Pruritus", "Dermatitis Eczema" ], "interventions": [ { "name": "ASN008 TG", "type": "DRUG" }, { "name": "Placebo TG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Asana BioSciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 24, "start_date": "2019-01-14", "completion_date": "2020-03-20", "has_results": false, "last_update_posted_date": "2023-05-09", "last_synced_at": "2026-10-10T17:17:41.369Z", "location_count": 4, "location_summary": "Cortland, New York • High Point, North Carolina • San Antonio, Texas + 1 more", "locations": [ { "city": "Cortland", "state": "New York" }, { "city": "High Point", "state": "North Carolina" }, { "city": "San Antonio", "state": "Texas" }, { "city": "West Bend", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03798561" }, { "nct_id": "NCT03630939", "title": "A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Psoriatic Plaque" ], "interventions": [ { "name": "ESR-114", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Escalier Biosciences B.V.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 104, "start_date": "2018-08-09", "completion_date": "2019-06-12", "has_results": false, "last_update_posted_date": "2020-07-29", "last_synced_at": "2026-10-10T17:17:41.369Z", "location_count": 8, "location_summary": "Santa Monica, California • Tampa, Florida • Fridley, Minnesota + 5 more", "locations": [ { "city": "Santa Monica", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Fridley", "state": "Minnesota" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03630939" }, { "nct_id": "NCT02709005", "title": "Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bacterial Vaginosis" ], "interventions": [ { "name": "5% Monolaurin Vaginal Gel", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 109, "start_date": "2016-04-14", "completion_date": "2017-12-11", "has_results": true, "last_update_posted_date": "2018-12-28", "last_synced_at": "2026-10-10T17:17:41.369Z", "location_count": 3, "location_summary": "Iowa City, Iowa • Durham, North Carolina • Cincinnati, Ohio", "locations": [ { "city": "Iowa City", "state": "Iowa" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02709005" }, { "nct_id": "NCT02120924", "title": "A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rosacea" ], "interventions": [ { "name": "Azelaic acid", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" }, { "name": "Finacea", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1009, "start_date": "2013-07", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2020-06-02", "last_synced_at": "2026-10-10T17:17:41.369Z", "location_count": 30, "location_summary": "Fremont, California • Santa Monica, California • Brandon, Florida + 26 more", "locations": [ { "city": "Fremont", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Brandon", "state": "Florida" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02120924" }, { "nct_id": "NCT06568627", "title": "A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Venous Leg Ulcer (VLU)" ], "interventions": [ { "name": "EscharEx (EX-03)", "type": "DRUG" }, { "name": "Placebo (Gel vehicle)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MediWound Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 216, "start_date": "2025-06-01", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-10T17:17:41.369Z", "location_count": 19, "location_summary": "Phoenix, Arizona • Fresno, California • Los Angeles, California + 15 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06568627" } ] }